These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4674133

  • 1. An evaluation of antibodies and clinical resistance to salmon calcitonin.
    Singer FR, Aldred JP, Neer RM, Krane SM, Potts JT, Bloch KJ.
    J Clin Invest; 1972 Sep; 51(9):2331-8. PubMed ID: 4674133
    [Abstract] [Full Text] [Related]

  • 2. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S, Rosenberg E, Haddad JG.
    Lancet; 1974 Dec 14; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract] [Full Text] [Related]

  • 3. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG, Caldwell JG.
    J Clin Invest; 1972 Dec 14; 51(12):3133-41. PubMed ID: 4674398
    [Abstract] [Full Text] [Related]

  • 4. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC, Meunier P, Terrier M, David L, Vignon G.
    Pathol Biol (Paris); 1975 May 14; 23(5):349-59. PubMed ID: 172838
    [Abstract] [Full Text] [Related]

  • 5. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC, Harrison JE, Wilson DR.
    Can Med Assoc J; 1977 Nov 05; 117(9):1031-4. PubMed ID: 562231
    [Abstract] [Full Text] [Related]

  • 6. Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment.
    Woodhouse NJ, Mohamedally SM, Saed-Nejad F, Martin TJ.
    Br Med J; 1977 Oct 08; 2(6092):927-9. PubMed ID: 410477
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F, Ringe JD, Kruse HP.
    Dtsch Med Wochenschr; 1981 Nov 27; 106(48):1620-3. PubMed ID: 7308002
    [Abstract] [Full Text] [Related]

  • 8. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance.
    Singer FR, Fredericks RS, Minkin C.
    Arthritis Rheum; 1980 Oct 27; 23(10):1148-54. PubMed ID: 7000081
    [Abstract] [Full Text] [Related]

  • 9. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
    Reginster JY, Gennari C, Mautalen C, Deroisy R, Denis D, Lecart MP, Vandalem JL, Collette J, Franchimont P.
    Scand J Rheumatol; 1990 Oct 27; 19(1):83-6. PubMed ID: 2309107
    [No Abstract] [Full Text] [Related]

  • 10. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F, Baker RK, Wallach S.
    J Clin Invest; 1971 Sep 27; 50(9):1927-40. PubMed ID: 4935444
    [Abstract] [Full Text] [Related]

  • 11. Formation of antibodies to synthetic human calcitonin during treatment of Paget's disease.
    Dietrich FM, Fischer JA, Bijvoet OL.
    Acta Endocrinol (Copenh); 1979 Nov 27; 92(3):468-76. PubMed ID: 517048
    [Abstract] [Full Text] [Related]

  • 12. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K, Schmidt UJ, Abendroth K, Ansorg H, Graner H, Lindenhayn K, Schramm G, Kalbe I.
    Z Alternsforsch; 1978 Nov 27; 33(5):441-51. PubMed ID: 570764
    [Abstract] [Full Text] [Related]

  • 13. Functional significance of antibody formation after long-term salmon calcitonin therapy.
    Hosking DJ, Denton LB, Cadge B, Martin TJ.
    Clin Endocrinol (Oxf); 1979 Mar 27; 10(3):243-52. PubMed ID: 572275
    [Abstract] [Full Text] [Related]

  • 14. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
    Caniggia A, Nuti R, Vattimo A, Galli M, Turchetti V, Franci B, Martorelli T, Righi G.
    Minerva Med; 1983 Apr 28; 74(18):993-1010. PubMed ID: 6087215
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R, Dambacher MA, Perrenoud A, Simon C, Fischer JA.
    Am J Med; 1990 Aug 28; 89(2):181-4. PubMed ID: 2382666
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T, Fuss M, Brauman J, Orloff S, Bergans A, Corvilain J.
    Rev Rhum Mal Osteoartic; 1977 Jan 28; 44(1):59-66. PubMed ID: 319520
    [No Abstract] [Full Text] [Related]

  • 17. [Variations in parathormone serum levels during treatment of Paget's disease with calcitonin of human or salmon origin (author's transl)].
    Heynen G, Franchimont P, Gaspar S, Gysen P, Kanis JA.
    Ann Endocrinol (Paris); 1981 Jan 28; 42(3):265-75. PubMed ID: 7316460
    [Abstract] [Full Text] [Related]

  • 18. [Intermittent treatment of Paget's disease of bone with calcitonin: histological study].
    Eisinger J, Laponche AM.
    Rev Rhum Mal Osteoartic; 1976 Jan 28; 43(7-9):511-6. PubMed ID: 981933
    [Abstract] [Full Text] [Related]

  • 19. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease.
    Levy F, Muff R, Dotti-Sigrist S, Dambacher MA, Fischer JA.
    J Clin Endocrinol Metab; 1988 Sep 28; 67(3):541-5. PubMed ID: 3410939
    [Abstract] [Full Text] [Related]

  • 20. The therapeutic uses of calcitonin.
    Martin TJ.
    Scott Med J; 1978 Apr 28; 23(2):161-5. PubMed ID: 644299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.